Jump to navigation
Roche's boost comes partly from good news from Genentech, of which it's part owner. And it's getting a shot in the arm from Tamiflu, the company's flu treatment. Stephen Beard reports.
<iframe src="http://www.marketplace.org/node/14160/player/storyplayer" frameborder="0" scrolling="no" width="100%" height="240px"></iframe>